The researchers believe their treatment can reach clinical trials in just five years. We break down how it works.
A new medication is offering some ALS patients more hope than ever. It's actually slowing the disease down in some people ...
Employees with Kaige Kubota in Odessa came to Odessa College to spread awareness about amyotrophic lateral sclerosis.
Years into his ALS journey, he's now a full-time farmer, but it hasn't been an easy road. He first noticed something was ...
A plan to use new genetic techniques to treat non-genetic forms of ALS failed in an early study, Ionis and Biogen announced ...
A new amyotrophic lateral sclerosis (ALS) assessment called delta-FS — defined as the rate of decline over time in the ALS ...
Biogen and Ionis Pharmaceuticals said on Thursday they will terminate the development of their experimental treatment for ...
San Diego-based cannabis company Gelato Canna Co. announced the launch of its newest products, Geebs gummy edibles and pre ...
ALS patient Mathew Brown said he’s hopeful for future ALS patients after news this week of research at Western University of ...
Shares of Ionis Pharmaceuticals (NASDAQ: IONS) and Biogen (NASDAQ: BIIB) lost at least 2% in market cap on Thursday after the companies announced their decision to terminate the development of their i ...
When Zac Brown band member, John Briskell Hopkins, was diagnosed with ALS he and his wife made it their mission to help find ...
The stocks of Biogen Inc. and Ionis Pharmaceuticals Inc. were lower Thursday, after the partners said they were terminating ...